Children's Mercy Hospital Kansas City

Open enrollment with an early-phase pipeline tilt

According to ClinicalTrials.gov-derived indexes, Children's Mercy Hospital Kansas City sits in the top decile of US sponsors by registered trial count (#163 of 15,742 sponsors by registered trial count).

184 total trials 21 currently recruiting 140 completed early-phase tilt top decile by trial count

Children's Mercy Hospital Kansas City: 184 sponsored US clinical trials, 21 recruiting.

Children's Mercy Hospital Kansas City sponsors 184 registered US clinical trials on ClinicalTrials.gov, 21 of them currently recruiting, and 140 completed. 11 of these trials are in Phase 3-4 (later-stage) and 25 in Phase 1-2 (earlier-stage). The most-studied condition in this pipeline is Contraception, with 3 trials.

Top-decile sponsor footprint

Children's Mercy Hospital Kansas City ranks in the top decile of sponsors by registered trial count (#163 of 15,742 sponsors by registered trial count). Volume at this scale usually reflects a long institutional pipeline, read phase tilt and therapeutic areas below before treating it as current-year activity.

Trial completion reliability score

D 63/100

140 of 157 decided trials (Completed vs. Terminated on ClinicalTrials.gov) reached their planned completion (89.2%), vs. national p10 68.4% / p90 100% among 1,234 sponsors with at least 10 decided trials. Still-open trials (Recruiting, Active-not-recruiting, Not-yet-recruiting) are excluded since they have not reached an outcome yet.

Open and recent trials

184 total, page 2 of 4

COMPLETED NA

Reducing Adolescent Sexual and Mental Health Disparities by Increasing Access to Telemedicine and Mobile Care

NCT05031741

COMPLETED Early Phase 1

Naltrexone Neuroimaging

NCT04935931

COMPLETED NA

Reducing Adolescent Pregnancy in the Emergency Department

NCT04744155

COMPLETED

Contraception Perspectives in Adolescents in Haiti

NCT05252052

COMPLETED

The PaTHS Descriptive Correlational Longitudinal Study

NCT04785482

TERMINATED Phase 4

Use of Liquid Stable Levothyroxine in Trisomy 21 Pediatric Patients

NCT04747275

COMPLETED Early Phase 1

Inpatient Adolescent Contraception

NCT04423068

COMPLETED NA

Stay Active Physical Activity Program

NCT04675658

COMPLETED NA

Weigh Easy: Simplifying Home Weight Monitoring for Infants

NCT04384276

COMPLETED

Cardiac Acute Transitioning Care to Home (CATCH) App Data Repository

NCT04498728

COMPLETED Phase 2

Low Dose Daunorubicin in Pediatric Relapsed/Refractory Acute Leukemia

NCT04562792

COMPLETED NA

SexHealth Mobile: Integrating a Mobile Clinic and a Point-of-care Contraception Counseling and Access

NCT04227145

COMPLETED

SNOO Smart Sleeper for Infants With CHD

NCT04534335

COMPLETED NA

Ultrasound Evaluation Versus Direct Measurement of Uterine Cavity Length

NCT04425577

COMPLETED Phase 4

Oral Caffeine Use for Pain Management in AIS Patients After Spinal Fusion

NCT04950660

COMPLETED NA

Walking to School Supports

NCT04089020

COMPLETED

Parental Experience in the Single Ventricle Interstage Utilizing a mHealth Innovation: A Comparative Case Study

NCT03231020

COMPLETED

BabySparks Developmental Application Pilot Study

NCT03867903

COMPLETED Phase 2

The Role of Contrast Enhanced Ultrasound in Appendicitis

NCT03687502

TERMINATED NA

NEC Screening Abdominal Radiograph vs Bowel Ultrasound in Preemies

NCT03963011

COMPLETED NA

Brain, Appetite, Teens, and Exercise

NCT03783390

COMPLETED

Neuroimaging of Pain: Changes in Regional Brain Functioning Associated With Amplified Pain and Intensive Treatment

NCT03703921

COMPLETED Phase 4

Effect of Obesity on Proton Pump Inhibitors

NCT04248335

COMPLETED NA

High and Low Resource Interventions to Promote HPV Vaccines

NCT03824093

TERMINATED NA

Ultrasound Elastography to Predict Development of SOS

NCT03858530

COMPLETED

ILSI Energy Balance Study

NCT04142281

COMPLETED

Atomoxetine PBPK-PD Clinical Study

NCT03154359

COMPLETED NA

Enhanced SexHealth Intervention to Improve Adolescent Outcomes

NCT03341975

COMPLETED NA

Resetting the Default: Improving Provider-patient Communication to Reduce Antibiotic Misuse

NCT03037112

COMPLETED

Dose Effect Relationship of MTX and IBD

NCT03531593

COMPLETED

Pilot Data Collection for Activity, Adiposity, and Appetite in Adolescents

NCT03157063

COMPLETED

Frailty in Children With Cardiac Disease

NCT02999438

COMPLETED NA

Mic-Key Versus Mini One Family Preference Comparison

NCT03041649

COMPLETED Phase 2

Metabolic and Neuro-Endocrine Effect of Treating PCOS in Adolescents

NCT03981861

COMPLETED NA

Appendectomy Versus Non-Operative Treatment For Acute Non-Perforated Appendicitis in Children

NCT02687464

COMPLETED NA

Using Ultrasound Elastography to Predict Development of SOS

NCT02483481

TERMINATED Phase 2

Four Drug Reinduction With Bortezomib for Relapsed or Refractory ALL or LL in Children and Young Adults

NCT02535806

COMPLETED NA

A Preliminary Investigation of the Efficacy of Aromatherapy in Reducing Discomfort in Youth With Chronic Headache

NCT02440997

COMPLETED Phase 1

Genetic Variation and Variability in Posaconazole Pharmacokinetics in Children

NCT02358499

COMPLETED

Functional Dyspepsia Microbiome Study

NCT02340312

TERMINATED

A Study Comparing Factor Level and Inhibitor Titer Testing Results Drawn From Central Venous Lines and Venipuncture

NCT02402829

COMPLETED NA

Genomic Sequencing in Acutely Ill Neonates

NCT02225522

COMPLETED NA

Treatment of Prepubertal Labial Adhesions

NCT02218463

COMPLETED NA

Melatonin in Pediatric FD Population

NCT04684199

COMPLETED

Functional Dyspepsia (FD) - Clinical Response to Montelukast in Children

NCT02360696

COMPLETED Phase 1

Pharmacokinetics of Rosuvastatin and Atorvastatin in Pediatric Dyslipidemia Patients

NCT02364258

COMPLETED Phase 1

Statin Distribution

NCT02360826

COMPLETED NA

The Impact of IV Acetaminophen on Pain After Appendectomy for Perforated Appendicitis

NCT02881996

COMPLETED Phase 1

Fecal Microbiota Transplantation in Pediatric Patients

NCT02108821

COMPLETED NA

Randomized Crossover of NAVA and Synchronized Intermittent Pressure Ventilation in Neonates and Infants

NCT02518230

← Previous Page 2 of 4 Next →

What is open in the Children's Mercy Hospital Kansas City pipeline

21 recruiting of 184 indexed (11% open); 140 completed (76%).

Phase mix: 11 late (III/IV) vs 25 early (I/II) (early-phase heavy).

Top condition: Contraception (3 trials), 9 others listed.

How open-pipeline share is computed

Recruiting share is recruiting_count divided by trial_count for this sponsor in the public registry export. Status can change between pulls; treat the figure as a research-attention snapshot, not product availability.

Children's Mercy Hospital Kansas City: open-pipeline peers nationwide

Peers matched on 184 registered trials and 11% open enrollment, not the therapeutic-area sidebar.

Children's Mercy Hospital Kansas City sits at or above the median trial volume and below the median recruiting share among these 9 nationwide peers -- the two do not always move together. Source: ClinicalTrials.gov (2026-08-08 snapshot). 2×2 strategic matrix plotting 9 entities by Total trials (X) and Recruiting share (Y), with a crosshair dividing the plot into four quadrants. Higher volume & more openFocused & more openHigher volume, mostly closedSmaller & mostly closed 0200400600800 0%5%10%15%20% Total trials Recruiting share Children's Mercy Hospital Kansas CityBoston UniversityNational Human Genome Research Institute (NHGRI)Fox Chase Cancer CenterViiV HealthcareAlbert Einstein College of MedicineUniversity of MemphisJanssen Research & DevelopmentBarbara Ann Karmanos Cancer Institute
Children's Mercy Hospital Kansas City sits at or above the median trial volume and below the median recruiting share among these 9 nationwide peers -- the two do not always move together. Source: ClinicalTrials.gov (2026-08-08 snapshot).

Children's Mercy Hospital Kansas City sits at or above the median trial volume and below the median recruiting share among these 9 nationwide peers -- the two do not always move together.

Sponsors near 184 trials (± recruiting share)

Sponsors near 11% open enrollment (± trial volume)

What to do with this Children's Mercy Hospital Kansas City page

184 registered trials is a research-attention snapshot, not an endorsement of Children's Mercy Hospital Kansas City or any single study.

  • 21 of Children's Mercy Hospital Kansas City's trials are currently recruiting, check each one's own eligibility criteria before contacting a site. Browse recruiting trials
  • Contraception is the condition Children's Mercy Hospital Kansas City studies most, compare against other sponsors active in the same condition before evaluating a specific study. See Contraception trials
  • Bring the specific trial ID (NCT number) to your own doctor before enrolling, this page is a directory, not medical guidance. Read the trial-finding guide

Trial and recruiting counts reflect ClinicalTrials.gov registry status as of the data vintage above; individual trial eligibility and enrollment status can change.

Children's Mercy Hospital Kansas City pipeline card: 184 registered trials from official public datasets.Report a data error.